Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrasimod extension study in ulcerative colitis
NCT02536404Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Jan 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 2 trial of etrasimod in ulcerative colitis (UC), sponsored by Arena Pharmaceuticals, Inc.. Started Jan 2016; status: completed.
02
Drugs
etrasimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02536404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536404.